As of November 2024 Rapport Therapeutics has a market cap of A$1.18 Billion. This makes Rapport Therapeutics the world's 5949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 15th, 2024 the market cap of Rapport Therapeutics was reported to be: